首页> 外文期刊>Internal medicine. >The Clinical Characteristics of Two Anti-OJ (Anti-Isoleucyl-tRNA Synthetase) Autoantibody-Positive Interstitial Lung Disease Patients with Polymyositis/Dermatomyositis
【24h】

The Clinical Characteristics of Two Anti-OJ (Anti-Isoleucyl-tRNA Synthetase) Autoantibody-Positive Interstitial Lung Disease Patients with Polymyositis/Dermatomyositis

机译:两种抗OJ(抗异糖基-CRNA合成酶)自身抗体阳性间质性肺病患者的临床特征

获取原文
获取原文并翻译 | 示例
           

摘要

We herein report the clinical and laboratory characteristics of two anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibody-positive interstitial lung disease patients with polymyositis/dermatomyositis (PM/DM). We compared these characteristics with previously published findings. Previous reports and our present cases show that anti-OJ autoantibody-positive interstitial lung disease (ILD) patients with PM/DM lack the manifestations of Raynaud's phenomenon and sclerodactyly and show good prognoses and responses to glucocorticoid therapy. These results indicate that the presence of anti-OJ autoantibodies may be useful for predicting the prognosis of ILD and its clinical course in PM/DM patients.
机译:我们在此报告了两种抗OJ(抗异糖基-TRNA合成酶)的临床和实验室特征,具有多发性/皮质肌肌炎(PM / DM)的患者的两种抗OJ(抗异糖基-CRNA合成酶)患者。 我们将这些特征与先前发表的调查结果进行了比较。 以前的报道和我们的本病例表明,抗OJ自身抗体正性间质肺病(ILD)PM / DM患者缺乏Raynaud的现象和硬化性的表现,表现出良好的预测和对糖皮质激素治疗的反应。 这些结果表明,抗OJ自身抗体的存在可用于预测PM / DM患者ILD的预后及其临床过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号